您的当前位置:首页 > 行业数据 > 百利天恒:化药与中成药制剂业务板块收入拆分
图片属性
图片格式:PNG 图片大小:92KB 图片尺寸:1819*881
同报告图片
 / 4
百利天恒:化药与中成药制剂业务板块收入拆分_第1页
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
百利天恒:化药与中成药制剂业务板块收入拆分_第2页
百利天恒:化药与中成药制剂业务板块收入拆分_第3页
百利天恒:化药与中成药制剂业务板块收入拆分_第4页
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
百利天恒:化药与中成药制剂业务板块收入拆分_第5页
所属报告: 百利天恒-公司研究报告-双抗ADC先锋携手BMS逐鹿全球-250126(54页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠